Anti-MYCN Polyclonal Antibody from ProteoGenix; catalogue ARO-A22058; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-MYCN Polyclonal Antibody: A Powerful Tool for Targeted Biotech Research
The Anti-MYCN Polyclonal Antibody is a cutting-edge biotech product that has been specifically designed to target the MYCN protein, a critical factor in the development and progression of various cancers. This antibody is a highly effective tool for researchers looking to study the role of MYCN in cancer biology and develop potential treatments.
The MYCN protein is a transcription factor that plays a crucial role in regulating cell growth and proliferation. It is known to be overexpressed in several types of cancer, including neuroblastoma, medulloblastoma, and small cell lung cancer. By targeting MYCN, the Anti-MYCN Polyclonal Antibody helps researchers gain a better understanding of the molecular mechanisms involved in cancer development and progression.
The Anti-MYCN Polyclonal Antibody is widely used in various research applications, including western blotting, immunoprecipitation, and immunofluorescence. Its high specificity and sensitivity make it an ideal choice for detecting and quantifying MYCN protein levels in cancer cells and tissues. This antibody can also be used for in vitro and in vivo studies to investigate the effects of MYCN inhibition on cancer cell growth and survival.
The Anti-MYCN Polyclonal Antibody has been successfully used in numerous research studies to uncover the role of MYCN in cancer biology. For example, it has been used to demonstrate the correlation between MYCN amplification and poor prognosis in neuroblastoma patients. Additionally, this antibody has been used to identify MYCN as a key regulator of drug resistance in small cell lung cancer. These findings highlight the potential of the Anti-MYCN Polyclonal Antibody in advancing our understanding of cancer and developing targeted therapies.
In conclusion, the Anti-MYCN Polyclonal Antibody is a valuable tool for researchers in the biotech industry. Its ability to specifically target the MYCN protein makes it an essential component in studying the role of MYCN in cancer and developing potential treatments. With its wide range of applications and proven effectiveness in various experimental settings, this antibody is a must-have for any biotech laboratory conducting cancer research.
Keywords: Anti-MYCN Polyclonal Antibody, MYCN protein, cancer biology, western blotting, immunoprecipitation, immunofluorescence, cancer development, drug resistance, targeted therapies.
ProteoGenix catalogue number ARO-A22058. For research use only.
Target: N-myc proto-oncogene protein; Class E basic helix-loop-helix protein 37; bHLHe37; MYCN; BHLHE37; NMYC; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| N-myc proto-oncogene protein; Class E basic helix-loop-helix protein 37; bHLHe37; MYCN; BHLHE37; NMYC |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.